The Commonwealth Therapeutic Goods Administration (TGA) today released a summary for patients about the national review of the scientific evidence for the use of cannabis medicines in five areas: palliative care, nausea and vomiting, epilepsy, multiple sclerosis and pain.

The Commonwealth Therapeutic Goods Administration (TGA) today released a summary for patients about the national review of the scientific evidence for the use of cannabis medicines in five areas: palliative care, nausea and vomiting, epilepsy, multiple sclerosis and pain. 

More information is available on the TGA website and can be found here.

Contact:

Phone: